Novel Tepotinib derivative and preparation method thereof and application of derivative in antitumor drug

A derivative, a new type of technology, applied in the new Tepotinib derivative and preparation, the application field of anti-tumor drugs, can solve the problem of low bioavailability

Inactive Publication Date: 2018-11-06
SYMEPILIN PHARMA CO LTD
View PDF0 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, Tepotinib also has its own shortcomings. Due to the presence of easily metabolized site...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel Tepotinib derivative and preparation method thereof and application of derivative in antitumor drug
  • Novel Tepotinib derivative and preparation method thereof and application of derivative in antitumor drug
  • Novel Tepotinib derivative and preparation method thereof and application of derivative in antitumor drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0104] Embodiment 1: antitumor compound 5b

[0105] The antitumor compound 5b has a structural formula of formula 21, and the synthesis steps are as follows:

[0106]

[0107] Preparation of Intermediate 2: Add 32 mL of toluene solution containing 5-fluoro-2-chloropyrimidine (33 mmol) to an aqueous solution of sodium carbonate (66 mmol) (32 mL of water), add bis(triphenylphosphine) palladium chloride ( 0.33mmol), and 65mL of an ethanol solution of acetylphenylboronic acid (32mmol) was added dropwise. The reaction was stirred at 80°C under nitrogen for 18 hours, cooled to room temperature, and filtered. Ethyl acetate and water were added to the filtrate, the organic phase was separated, and dried over anhydrous sodium sulfate. The crude product was separated by silica gel column chromatography (ethyl acetate:petroleum ether, 8:1) to obtain a light yellow solid, namely intermediate 2. Yield 61%. 1 H NMR (400MHz, CDCl 3 )δ8.98(t,J=1.6Hz,1H),8.70(s,2H),8.59(s,1H),8.09(s,1H)...

Embodiment 2

[0111] Embodiment 2: antitumor compound 6a

[0112] Antitumor compound 6a, its structural formula is formula 22, and the synthesis steps are as follows:

[0113]

[0114] Preparation of Intermediate 3a: Sodium carbonate (66mmol) in water (32mL) was added to a toluene solution (32mL) containing 5-fluoro-2-chloropyrimidine (33mmol), bis(triphenylphosphine)palladium dichloride was added (0.33mmol), dropwise the ethanol (65mL) solution of hydroxymethylphenylboronic acid (32mmol), under nitrogen protection, stir at 80 ℃ for 18 hours, cool to room temperature, filter, add ethyl acetate and water in the filtrate, The organic phase was separated and dried over anhydrous sodium sulfate. The crude product was subjected to silica gel column chromatography (ethyl acetate:petroleum ether, 8:1), and a light yellow solid was obtained, namely intermediate 3a. The yield was 61%. 1 H NMR (400MHz, CDCl 3 )δ8.66(d,J=1.8Hz,1H),8.37(d,J=4.9Hz,1H),8.31(s,1H),7.54-7.46(m,1H),4.80(s,1H), 1.99(s,...

Embodiment 3

[0117] Embodiment 3: antitumor compound (R)-5b

[0118] The antitumor compound (R)-5b has a structural formula of formula 23, and the synthesis steps are as follows:

[0119]

[0120] Preparation of intermediate 8b: Add sodium hydride (60%, 1.5 mmol) to 1-methylpiperidine-3-methanol (1.2 mmol) in N,N-dimethylformamide 10 mL in portions at 0 °C , stirred for 15 minutes, then slowly added intermediate 2 to the mixture at 0°C, slowly warmed the reaction mixture to room temperature and stirred for 1 hour, diluted the reaction solution with water, extracted with ethyl acetate, dried the combined organic layer, and spun The crude product was obtained by evaporation, and the crude product was purified by silica gel column chromatography (dichloromethane:methanol=20:1) to obtain a pale yellow oil, namely intermediate 8b, yield: 73%. 1 H NMR (400MHz, CDCl 3 )δ8.93(t, J=1.5Hz, 1H), 8.56(dt, J=7.8, 1.3Hz, 1H), 8.47(s, 2H), 8.04(dt, J=7.7, 1.3Hz, 1H), 7.57(t, J=7.8Hz, 1H), 3.97(d, J...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a novel Tepotinib derivative and a preparation method thereof and an application of the derivative in an antitumor drug. According to the invention, a chiral structure is introduced in molecules, a hydrogen isotope deuterium is introduced in an easily metabolical part in the molecules, and atoms of sulfur, selenium and sulfoxide or groups are introduced in the molecules. The antineoplastic active experiments (having c-Met-expressed tumor cells) on a cell level proves that the compound has excellent antineoplastic activity, and the stability of the antineoplastic compound is obviously increased.

Description

technical field [0001] The invention relates to the field of medicines, in particular to a novel Tepotinib derivative, a preparation method and its application in antitumor drugs. Background technique [0002] Cancer is one of the major diseases that seriously endanger people's health. According to the 2017 national cancer statistics released by the National Cancer Center, there were 3.804 million new cases of malignant tumors nationwide, equivalent to an average of more than 10,000 people diagnosed with cancer every day. The top five cancers in urban areas are lung cancer, colorectal cancer, gastric cancer, liver cancer, and female breast cancer; the top five cancers in rural areas are lung cancer, gastric cancer, liver cancer, esophageal cancer, and colorectal cancer. Therefore, it is extremely important to find and develop effective new anticancer drugs. [0003] The c-Met proto-oncogene belongs to the Ron subfamily of the tyrosine kinase (Protein Tyrosine Kinases, PTKs...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D401/14C07D403/10A61P35/00
CPCA61P35/00C07D401/14C07D403/10C07D401/12C07D239/30C07B2200/05C07B59/002C07D403/14
Inventor 黎兴术胡金辉安佰娇陈新滋黄玲
Owner SYMEPILIN PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap